CY1109812T1 - Αντιγονικα πολυπεπτιδια neisseira meningitidis (μηνιγγιτιδοκοκκου), αντιστοιχα πολυνουκλεοτιδια και προστατευτικα αντισωματα - Google Patents

Αντιγονικα πολυπεπτιδια neisseira meningitidis (μηνιγγιτιδοκοκκου), αντιστοιχα πολυνουκλεοτιδια και προστατευτικα αντισωματα

Info

Publication number
CY1109812T1
CY1109812T1 CY20101100152T CY101100152T CY1109812T1 CY 1109812 T1 CY1109812 T1 CY 1109812T1 CY 20101100152 T CY20101100152 T CY 20101100152T CY 101100152 T CY101100152 T CY 101100152T CY 1109812 T1 CY1109812 T1 CY 1109812T1
Authority
CY
Cyprus
Prior art keywords
polypeptides
neisseira
antigenous
meningitidis
protective antibodies
Prior art date
Application number
CY20101100152T
Other languages
English (en)
Inventor
Catherine Defrenne
Christine Delmelle
Jean-Louis Ruelle
Original Assignee
Glaxosmithkline Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9905815.8A external-priority patent/GB9905815D0/en
Priority claimed from GBGB9909094.6A external-priority patent/GB9909094D0/en
Priority claimed from GBGB9909503.6A external-priority patent/GB9909503D0/en
Priority claimed from GBGB9909787.5A external-priority patent/GB9909787D0/en
Priority claimed from GBGB9910710.4A external-priority patent/GB9910710D0/en
Application filed by Glaxosmithkline Biologicals S.A. filed Critical Glaxosmithkline Biologicals S.A.
Publication of CY1109812T1 publication Critical patent/CY1109812T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Η εφεύρεση παρέχει πολυπεπτίδια και πολυνουκλεοτίδια BASB082, BASB083, BASB091, BASB092 και BASB101 τα οποία κωδικοποιούν τα πολυπεπτίδια BASB082, BASB083, BASB091, BASB092 και BASB101 και μεθόδους για την παραγωγή τέτοιων πολυπεπτιδίων με ανασυνδυαστικές τεχνικές. Παρέχονται επίσης διαγνωστικές, προφυλακτικές και θεραπευτικές χρήσεις.
CY20101100152T 1999-03-12 2010-02-12 Αντιγονικα πολυπεπτιδια neisseira meningitidis (μηνιγγιτιδοκοκκου), αντιστοιχα πολυνουκλεοτιδια και προστατευτικα αντισωματα CY1109812T1 (el)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GBGB9905815.8A GB9905815D0 (en) 1999-03-12 1999-03-12 Novel compounds
GBGB9909094.6A GB9909094D0 (en) 1999-04-21 1999-04-21 Novel compounds
GBGB9909503.6A GB9909503D0 (en) 1999-04-23 1999-04-23 Novel compounds
GBGB9909787.5A GB9909787D0 (en) 1999-04-28 1999-04-28 Novel compounds
GBGB9910710.4A GB9910710D0 (en) 1999-05-07 1999-05-07 Novel compounds
EP00909329A EP1163343B1 (en) 1999-03-12 2000-03-07 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies

Publications (1)

Publication Number Publication Date
CY1109812T1 true CY1109812T1 (el) 2014-09-10

Family

ID=27517501

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100152T CY1109812T1 (el) 1999-03-12 2010-02-12 Αντιγονικα πολυπεπτιδια neisseira meningitidis (μηνιγγιτιδοκοκκου), αντιστοιχα πολυνουκλεοτιδια και προστατευτικα αντισωματα

Country Status (11)

Country Link
US (3) US7666988B1 (el)
EP (3) EP2163628A3 (el)
AT (1) ATE451461T1 (el)
AU (1) AU3164600A (el)
CA (1) CA2365102A1 (el)
CY (1) CY1109812T1 (el)
DE (1) DE60043499D1 (el)
DK (1) DK1163343T3 (el)
ES (1) ES2337650T3 (el)
PT (1) PT1163343E (el)
WO (1) WO2000055327A2 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808866D0 (en) * 1998-04-24 1998-06-24 Smithkline Beecham Biolog Novel compounds
EP2261343A3 (en) * 1998-05-01 2012-01-18 Novartis Vaccines and Diagnostics, Inc. Neisseria meningitidis antigens and compositions
EP2163628A3 (en) 1999-03-12 2010-06-02 GlaxoSmithKline Biologicals S.A. Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
US6798520B2 (en) 2002-03-22 2004-09-28 Diversa Corporation Method for intensifying the optical detection of samples that are held in solution in the through-hole wells of a holding tray
GB0816447D0 (en) 2008-09-08 2008-10-15 Glaxosmithkline Biolog Sa Vaccine
CA2792683A1 (en) 2010-03-10 2011-09-15 Glaxosmithkline Biologicals S.A. Neisserial fhbp vaccine composition
JP2013522177A (ja) * 2010-03-11 2013-06-13 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム グラム陰性細菌性、例えば髄膜炎菌性の感染または疾患に対する免疫原性組成物またはワクチン
WO2013113917A1 (en) 2012-02-02 2013-08-08 Novartis Ag Promoters for increased protein expression in meningococcus

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US121528A (en) 1871-12-05 Improvement in bridle-blinders for horses
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
GB9022190D0 (en) 1990-10-12 1990-11-28 Perham Richard N Immunogenic material
PL170980B1 (pl) 1992-06-25 1997-02-28 Smithkline Beecham Biolog Szczepionka PL PL PL PL PL PL PL
ES2162139T5 (es) 1993-03-23 2008-05-16 Smithkline Beecham Biologicals S.A. Composiciones de vacuna que contienen monofosforil-lipido a 3-o-desacilado.
AU695869B2 (en) 1993-04-06 1998-08-27 Fred Hutchinson Cancer Research Center Chimeric cytokine receptors in lymphocytes
JPH08508889A (ja) 1993-06-07 1996-09-24 アムジエン・インコーポレーテツド ハイブリッドレセプター分子
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
AU713040B2 (en) 1994-07-15 1999-11-18 University Of Iowa Research Foundation, The Immunomodulatory oligonucleotides
US6121037A (en) 1994-10-18 2000-09-19 Stojiljkovic; Igor Bacterial hemoglobin receptor genes
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
FR2751000B1 (fr) 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
EP1900818A3 (en) * 1997-11-06 2008-06-11 Novartis Vaccines and Diagnostics S.r.l. Neisserial antigens
EP2261343A3 (en) * 1998-05-01 2012-01-18 Novartis Vaccines and Diagnostics, Inc. Neisseria meningitidis antigens and compositions
US20070026021A1 (en) 1998-05-01 2007-02-01 Chiron S.R.I. Neisseria meningitidis antigens and compositions
JP2004511201A (ja) 1998-10-09 2004-04-15 カイロン　コーポレイション ナイセリアゲノム配列およびそれらの使用方法
EP2163628A3 (en) 1999-03-12 2010-06-02 GlaxoSmithKline Biologicals S.A. Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
CA2371032A1 (en) 1999-04-30 2000-11-09 Chiron Corporation Neisseria genomic sequences and methods of their use
GB0011108D0 (en) 2000-05-08 2000-06-28 Microscience Ltd Virulence gene and protein and their use

Also Published As

Publication number Publication date
US20120328622A1 (en) 2012-12-27
EP1163343A2 (en) 2001-12-19
WO2000055327A2 (en) 2000-09-21
PT1163343E (pt) 2010-02-23
EP2163628A2 (en) 2010-03-17
EP1163343B1 (en) 2009-12-09
EP2270169A3 (en) 2011-06-15
US8217159B2 (en) 2012-07-10
AU3164600A (en) 2000-10-04
US8580279B2 (en) 2013-11-12
DE60043499D1 (de) 2010-01-21
US7666988B1 (en) 2010-02-23
DK1163343T3 (da) 2010-04-19
WO2000055327A3 (en) 2001-01-04
US20100184139A1 (en) 2010-07-22
ATE451461T1 (de) 2009-12-15
ES2337650T3 (es) 2010-04-28
EP2270169A2 (en) 2011-01-05
CA2365102A1 (en) 2000-09-21
EP2163628A3 (en) 2010-06-02

Similar Documents

Publication Publication Date Title
CY1105676T1 (el) Basb029 πολυνουκλεοτιδιο (πολυνουκλεοτιδια) και πολυπεπτιδια απο neisseria meningitidis
CY1109812T1 (el) Αντιγονικα πολυπεπτιδια neisseira meningitidis (μηνιγγιτιδοκοκκου), αντιστοιχα πολυνουκλεοτιδια και προστατευτικα αντισωματα
CY1113109T1 (el) Νεες ενωσεις
CY1105820T1 (el) Basb027 πρωτεϊνες και γονιδια απο moraxella catarrhalis, αντιγονα, αντισωματα και χρησεις
CY1108280T1 (el) Basb205 πολυπεπτιδια και πολυνουκλεοτιδια που τα κωδικοποιουν
NO20005952D0 (no) Neisseria Meningitidis antigene polypeptider, korresponderende polynukleotider og beskyttende antistoffer
DK1112366T3 (da) Polynucleotider og polypeptider BASB033 fra Neisseria Meningitidis samt deres anvendelser
CY1108554T1 (el) Ανοσογονικα πολυπεπτιδια που λαμβανονται απο moraxella catarrhalis και χρησεις αυτων
GB9809683D0 (en) Novel compounds
GB9812163D0 (en) Novel compounds
TR200100741T2 (tr) Moraxella catarrhalis BASB034 polipeptidleri ve kullanımları
AU4567300A (en) Novel compounds
WO2000042191A3 (en) Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
GB9918208D0 (en) Novel compounds
ATE443715T1 (de) Polypeptide aus haemophilus influenza
CY1106060T1 (el) Basb11 πολυπεπτιδιο και πολυνουκλεοτιδιο απο moraxella catharrhalis
GB9918302D0 (en) Novel compounds
ATE293693T1 (de) Moraxella catarrhalis antigen basb117
GB0025169D0 (en) Novel compounds
ATE293692T1 (de) Moraxella catarrhalis antigen basb120